SEC Filing Summary: Xenomics, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Xenomics, Inc. on October 14, 2008, covering events occurring on October 8, 2008. The filing discloses the creation of a direct financial obligation through a related-party transaction.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or margin data. The specific financial event reported is as follows:
- New Debt Obligation: $120,000 principal amount.
- Lender: Dr. Kira Sheinerman (a director of the Company).
- Interest Rate: 0% (Non-interest bearing).
- Maturity Date: One year from the date of the loan (October 8, 2009).
- Terms: No prepayment penalty; no cross-default provisions.
Material Changes
The Company incurred a new liability of $120,000. This represents a related-party transaction approved by the Board of Directors, with Dr. Sheinerman abstaining from the vote. No prior comparable period data is provided in this specific filing to assess year-over-year changes.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the disclosure of the new debt obligation. The transaction is classified under Item 2.04 (Creation of a Direct Financial Obligation).
Investor Verification Checklist
- Verify the total outstanding debt of Xenomics, Inc. as of the filing date to assess the impact of this $120,000 note on overall leverage.
- Confirm the Company's current cash position and liquidity status to evaluate the ability to repay the principal in October 2009.
- Review the Company's most recent 10-K or 10-Q filings for context on revenue and operating cash flows, as this 8-K does not contain such data.
- Check for any subsequent filings regarding the repayment or refinancing of this specific promissory note.